Embla Medical hf (OCSE:EMBLA)
kr 35.3 0.8 (2.32%) Market Cap: 15.07 Bil Enterprise Value: 18.38 Bil PE Ratio: 31.89 PB Ratio: 2.86 GF Score: 71/100

Q2 2022 Ossur hf Earnings Call Transcript

Jul 21, 2022 / 07:00AM GMT
Release Date Price: kr31.5 (+5.00%)
Operator

Good day, and thank you for standing by. Welcome to the Ãssur Q2 Results 2022 Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Sveinn Solvason, President and CEO. Please go ahead, sir.

Sveinn Solvason;ssur hf.;President;CEO
Ã

&

Thank you very much. I would like to welcome you to the Ãssur investor conference call where we will cover the results for the second quarter of 2022. My name is Sveinn Solvason, and I am the President and CEO. We will go through the highlights for the quarter and a question-and-answer session will then follow.

Now sales amounted to $181 million, which corresponds to a negative 1% organic growth. Sales growth continues in EMEA and all key markets in APAC, except for China. And it's good to see that Australia is now back on track in the quarter. As projected, China was impacted by the COVID-19-related lockdowns, and we continue also to suspend our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot